Evidence map›Paper›PMID 39382811›Full record

ArticleEJNMMI research2024

A study method using early dynamic acquisition of [

Ines Barrat, Marc-Etienne Meyer, Alexandre Coutte, Mathieu Boone, Roger Bouzerar, Pascal Bailly

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. A Practical, Short, [Journal of clinical medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ines BarratNuclear Medicine Department, Amiens University Medical Center, Amiens, France.
Marc-Etienne MeyerNuclear Medicine Department, Amiens University Medical Center, Amiens, France.
Alexandre CoutteRadiotherapy Department, Amiens University Medical Center, Amiens, France.
Mathieu BooneMedical Oncology Department, Amiens University Medical Center, Amiens, France.
Roger BouzerarNuclear Medicine Department, Amiens University Medical Center, Amiens, France.
Pascal BaillyNuclear Medicine Department, Amiens University Medical Center, Amiens, France. Bailly.Pascal@chu-amiens.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt is difficult to distinguish between the brain metastasis progression (BMP) and brain radionecrosis (BRN) on the basis of

resultsSeven lesions were classified as BMP and twelve were classified as BRN. Statistically significant intergroup differences in the VOImax/CLmean and VOImax/WMmean activity ratios were observed for both the clinical volume and the early acquisition. The best performing quantitative variable was the VOImax/CLmean ratio on early acquisition, with a diagnostic accuracy of 94.7%, a sensitivity of 100%, and a specificity of 91.7%.

conclusionThe

Indexed as

Brain metastasisDynamic acquisitionFDOPA PETProgressionRadionecrosis

Identifiers

PMID39382811
PMCPMC11465032

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.